Dexibuprofen
MUSCULO-SKELETAL SYSTEM
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Dexibuprofen is a drug catalogued in DrugCentral. DrugCentral lists 6 molecular targets, including PTGS1, PTGS2 and PTGS1. Recorded indications include Dysmenorrhea, Fever, Headache disorder and Juvenile rheumatoid arthritis.
- Molecular targets: PTGS1, PTGS2, PTGS1 and PTGS2 (6 listed in DrugCentral).
- Indications: Dysmenorrhea, Fever, Headache disorder, Juvenile rheumatoid arthritis and Osteoarthritis and others.
- ATC code: M01AE14 (Propionic acid derivatives).
- Molecular formula: C13H18O2; molecular weight 206.28 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (7)
- Dysmenorrhea
- Fever
- Headache disorder
- Juvenile rheumatoid arthritis
- Osteoarthritis
- Pain
- Rheumatoid arthritis
Mechanism & targets
Molecular targets (6)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Prostaglandin G/H synthase 1 | PTGS1 | unknown | IC50 7.01 |
| Prostaglandin G/H synthase 2 | PTGS2 | unknown | IC50 6.14 |
| Prostaglandin G/H synthase 1 | PTGS1 | unknown | IC50 5.83 |
| Prostaglandin G/H synthase 2 | PTGS2 | unknown | IC50 5.82 |
| Aldo-keto reductase family 1 member C3 | AKR1C3 | unknown | IC50 4.49 |
| Aldo-keto reductase family 1 member C2 | AKR1C2 | unknown | IC50 4.37 |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
M01AE14 | MUSCULO-SKELETAL SYSTEM › ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS › ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS › Propionic acid derivatives |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Hemianopia | 141.7 |
| White blood cell count decreased | 63.5 |
| Skin fissures | 60.9 |
| Sopor | 48.9 |
| Ascites | 43.0 |
| Thrombocytopenia | 40.4 |
Chemical structure
| Molecular formula | C13H18O2 |
|---|---|
| Molecular weight | 206.28 g/mol |
| CAS number | 51146-56-6 |
| InChIKey | HEFNNWSXXWATRW-JTQLQIEISA-N |
| PubChem CID | 39912 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Dexibuprofen used for?
DrugCentral lists the following indications for Dexibuprofen: Dysmenorrhea, Fever, Headache disorder, Juvenile rheumatoid arthritis, Osteoarthritis, Pain and Rheumatoid arthritis.
How does Dexibuprofen work?
Its molecular targets in DrugCentral include PTGS1, PTGS2, PTGS1 and PTGS2.
What is the chemical formula of Dexibuprofen?
Dexibuprofen has the molecular formula C13H18O2 and a molecular weight of 206.28 g/mol.
Browse: all drugs starting with D · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 3851 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL175 — compound record and bioactivity
- PubChem CID 39912 — chemical identifiers
- DrugBank DB09213 — drug record
- FDA UNII 671DKG7P5S — substance identity
- UniProt P23219 (PTGS1) — target protein
- UniProt P35354 (PTGS2) — target protein
- UniProt P42330 (AKR1C3) — target protein
- UniProt P52895 (AKR1C2) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.